Episome partitioning and symmetric cell divisions: Quantifying the role of random events in the persistence of HPV infections.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
09 2021
Historique:
received: 12 04 2021
accepted: 16 08 2021
revised: 17 09 2021
pubmed: 8 9 2021
medline: 15 12 2021
entrez: 7 9 2021
Statut: epublish

Résumé

Human Papillomaviruses (HPV) are one of the most prevalent sexually transmitted infections (STI) and the most oncogenic viruses known to humans. The vast majority of HPV infections clear in less than 3 years, but the underlying mechanisms, especially the involvement of the immune response, are still poorly known. Building on earlier work stressing the importance of randomness in the type of cell divisions in the clearance of HPV infection, we develop a stochastic mathematical model of HPV dynamics that combines the previous aspect with an explicit description of the intracellular level. We show that the random partitioning of virus episomes upon stem cell division and the occurrence of symmetric divisions dramatically affect viral persistence. These results call for more detailed within-host studies to better understand the relative importance of stochasticity and immunity in HPV infection clearance.

Identifiants

pubmed: 34491986
doi: 10.1371/journal.pcbi.1009352
pii: PCOMPBIOL-D-21-00650
pmc: PMC8448377
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009352

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Sci (Lond). 2006 May;110(5):525-41
pubmed: 16597322
Virus Res. 2017 Mar 2;231:119-127
pubmed: 28040475
J Theor Biol. 2014 Jun 7;350:98-109
pubmed: 24412334
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):709-15
pubmed: 17416761
Vaccine. 2012 Nov 20;30 Suppl 5:F55-70
pubmed: 23199966
Int J Gynecol Cancer. 2009 May;19(4):508-12
pubmed: 19509544
J Virol. 2012 Mar;86(6):3276-83
pubmed: 22238312
Sex Transm Dis. 2014 Nov;41(11):660-4
pubmed: 25299412
Nat Cell Biol. 2016 Feb;18(2):145-56
pubmed: 26641719
J Natl Cancer Inst. 2011 Mar 2;103(5):368-83
pubmed: 21282563
Science. 2012 Aug 31;337(6098):1091-3
pubmed: 22821983
Lancet Glob Health. 2016 Sep;4(9):e609-16
pubmed: 27470177
N Engl J Med. 2013 Dec 12;369(24):2324-31
pubmed: 24328466
Rev Med Virol. 2015 Mar;25 Suppl 1:2-23
pubmed: 25752814
Head Neck Pathol. 2012 Jul;6 Suppl 1:S3-15
pubmed: 22782219
Evol Med Public Health. 2015 Jan 28;2015(1):32-51
pubmed: 25634317
Oral Oncol. 2014 May;50(5):380-6
pubmed: 24461628
Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Aug;76(2 Pt 1):021910
pubmed: 17930068
Viruses. 2017 Sep 19;9(9):
pubmed: 28925973
Cell. 2017 Sep 7;170(6):1164-1174.e6
pubmed: 28886384
Biol Chem. 2004 Aug;385(8):671-82
pubmed: 15449703
Cancers (Basel). 2016 Oct 19;8(10):
pubmed: 27775564
Clin Diagn Lab Immunol. 2001 Mar;8(2):209-20
pubmed: 11238198
Presse Med. 2014 Dec;43(12 Pt 2):e413-21
pubmed: 25448124
Gynecol Oncol. 2010 Jun;118(1 Suppl):S12-7
pubmed: 20494219
Papillomavirus Res. 2017 Jun;3:46-49
pubmed: 28720456
Viruses. 2015 Jul 16;7(7):3863-90
pubmed: 26193301
PLoS Comput Biol. 2015 Mar 13;11(3):e1004113
pubmed: 25769112
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
Virology. 2005 Jun 20;337(1):76-84
pubmed: 15914222
Am J Obstet Gynecol. 1970 Sep 1;108(1):8-17
pubmed: 5454588
J Virol. 2005 Jul;79(14):8920-32
pubmed: 15994786
Cold Spring Harb Symp Quant Biol. 2008;73:333-50
pubmed: 19022769
J Natl Cancer Inst. 2000 May 3;92(9):709-20
pubmed: 10793107
Gynecol Oncol. 2008 May;109(2 Suppl):S15-21
pubmed: 18474288
J Virol. 2018 Apr 13;92(9):
pubmed: 29467315
Gynecol Oncol. 2010 May;117(2 Suppl):S5-10
pubmed: 20304221
Clin Microbiol Rev. 2012 Apr;25(2):215-22
pubmed: 22491770
Nature. 2007 Mar 8;446(7132):185-9
pubmed: 17330052
Virol J. 2008 Oct 14;5:118
pubmed: 18854037
J Infect Dis. 1995 Jul;172(1):11-8
pubmed: 7797899
Nature. 2012 Aug 30;488(7413):S2-3
pubmed: 22932437
Curr Opin Virol. 2013 Aug;3(4):416-21
pubmed: 23816390
Proc Biol Sci. 2015 Jan 7;282(1798):20141069
pubmed: 25429011
Trends Microbiol. 2010 Oct;18(10):432-8
pubmed: 20739182
Vaccine. 2006 Mar 30;24 Suppl 1:S16-22
pubmed: 16219398

Auteurs

Thomas Beneteau (T)

Laboratoire MIVEGEC, Université de Montpellier, Centre national de la recherche scientifique, Institut de recherche pour le développement, Montpellier, France.

Christian Selinger (C)

Laboratoire MIVEGEC, Université de Montpellier, Centre national de la recherche scientifique, Institut de recherche pour le développement, Montpellier, France.

Mircea T Sofonea (MT)

Laboratoire MIVEGEC, Université de Montpellier, Centre national de la recherche scientifique, Institut de recherche pour le développement, Montpellier, France.

Samuel Alizon (S)

Laboratoire MIVEGEC, Université de Montpellier, Centre national de la recherche scientifique, Institut de recherche pour le développement, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH